NovaBridge Biosciences (NBP) Free Cash Flow (2019 - 2025)
NovaBridge Biosciences (NBP) reported Free Cash Flow of -$20.6 million for Q4 2025, up 18.05% year-over-year from -$17.4 million in Q4 2024, and down 362.72% on a QoQ basis from $7.8 million in Q3 2025.
NovaBridge Biosciences (NBP) has 4 years of Free Cash Flow data on file, last reported at -$20.6 million in Q4 2025.
- Quarterly Free Cash Flow rose 18.05% year-over-year to -$20.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12.8 million (down 412.74% YoY) and the FY2025 annual result came in at -$20.6 million, up 60.87% from the prior year.
- Free Cash Flow retreated to -$20.6 million in Q4 2025 per NBP's latest filing, from $7.8 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $22.6 million in Q3 2024 and bottomed at -$25.1 million in Q4 2024.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -20.60 Mn |
| Dec 31, 2025 | -20.60 Mn |
| Sep 30, 2025 | 7.84 Mn |
| Sep 30, 2025 | 7.84 Mn |
| Dec 31, 2024 | -25.13 Mn |
| Dec 31, 2024 | -25.13 Mn |
| Sep 30, 2024 | 22.65 Mn |
| Sep 30, 2024 | 22.65 Mn |
| Dec 31, 2020 | 151.41 Mn |
| Dec 31, 2020 | 151.41 Mn |
| Sep 30, 2020 | -33.64 Mn |
| Sep 30, 2020 | -33.64 Mn |
| Dec 31, 2019 | -33.04 Mn |
| Dec 31, 2019 | -33.04 Mn |